Your browser doesn't support javascript.
loading
State-of-the-Science of human papillomavirus vaccination in women with human immunodeficiency Virus: Summary of a scientific workshop.
Schuind, Anne E; Rees, Helen; Schiller, John; Mugo, Nelly; Dull, Peter; Barnabas, Ruanne; Clifford, Gary M; Liu, Gui; Madhi, Shabir A; Morse, Rebecca B; Moscicki, Anna-Barbara; Palefsky, Joel M; Plotkin, Stanley; Sierra, Mónica S; Slifka, Mark K; Vorsters, Alex; Kreimer, Aimée R; Didierlaurent, Arnaud M.
Afiliação
  • Schuind AE; PATH, Washington DC, United States.
  • Rees H; Wits Reproductive Health and HIV Institute (Wits RHI), University of the Witwatersrand, Johannesburg, South Africa.
  • Schiller J; National Cancer Institute, National Institutes of Health, Bethesda, United States.
  • Mugo N; Kenya Medical Research Institute, Nairobi, Kenya and Department of Global Health, University of Washington, Seattle, United States.
  • Dull P; Vaccine Development, Bill & Melinda Gates Foundation, Seattle, United States.
  • Barnabas R; Division of Infectious Diseases, Mass General Hospital, Harvard Medical School, Boston, United States.
  • Clifford GM; Early Detection, Prevention, and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Liu G; Department of Global Health, University of Washington, Seattle, United States.
  • Madhi SA; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Johannesburg, South Africa.
  • Morse RB; Centre of Vaccinology, University of Geneva, Switzerland.
  • Moscicki AB; Department of Pediatrics, University of California Los Angeles, Los Angeles, United States.
  • Palefsky JM; University of California, San Francisco School of Medicine, San Francisco, United States.
  • Plotkin S; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
  • Sierra MS; National Cancer Institute, National Institutes of Health, Bethesda, United States.
  • Slifka MK; Oregon Health & Science University, Beaverton, United States.
  • Vorsters A; Vaccine & Infectious Disease Institute, Centre for the Evaluation of Vaccination, University of Antwerp, Antwerp, Belgium.
  • Kreimer AR; National Cancer Institute, National Institutes of Health, Bethesda, United States.
  • Didierlaurent AM; Centre of Vaccinology, University of Geneva, Switzerland.
Prev Med Rep ; 35: 102331, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37576844
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 10_ODS3_salud_sexual_reprodutiva / 2_ODS3 Problema de saúde: 10_sexually_transmitted_infections / 2_cobertura_universal Tipo de estudo: Risk_factors_studies Idioma: En Revista: Prev Med Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 10_ODS3_salud_sexual_reprodutiva / 2_ODS3 Problema de saúde: 10_sexually_transmitted_infections / 2_cobertura_universal Tipo de estudo: Risk_factors_studies Idioma: En Revista: Prev Med Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos